Figure 6.
Hippocampal inflammation in CKD mice was effectively suppressed by AST-120 administration. Immunohistochemistry staining against IL-1β and IL-18 was used to examine hippocampal inflammation. There was significantly increased IL-1β (panel (A)) and IL-18 (panel (B)) expression in the hippocampal of CKD mice, which was effectively suppressed by AST-120 administration (panel (C)). Similarly, the Western blotting assay revealed increased IL-1β, IL-18, and caspase-1 expression in the hippocampus of CKD mice, which was reverted by AST-120 administration (panel (D,E)). The results suggested that decreased IS levels could ameliorate hippocampal inflammation. (Scale bar 100×: 200 μm, 400×: 50 μm, * p ≤ 0.1; ** p ≤ 0.01; *** p ≤ 0.00; n = 3 for immunohistochemistry, 6 images were taken from each animal; n = 6 for Western blotting).